- Information
FY 2025
- IR
Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2025 (unaudited) (Based on Japanese GAAP) （PDF:212KB）
- Information
Notice Concerning License Agreement for Know-How of Manufacturing and Sales of Electrical Insulating Paper and Acquisition of Inventories （PDF:196KB）
- IR
Results of Operations for the First Half of the Fiscal Year Ending March 31, 2026 （PDF:1.09MB）
- IR
Notice Regarding Disposal of Treasury Shares Associated with the Introduction of a Stock Grant ESOP Trust System （PDF:99.1KB）
- IR
Notice Regarding the Introduction of a Stock Grant ESOP Trust （PDF:161KB）
- IR
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2025 (unaudited) (Based on Japanese GAAP) （PDF:218KB）
- Information
Notice Concerning Absorption Merger of Wholly-Owned Subsidiary （PDF:228KB）
- IR
Notice Concerning Change of Shareholder Benefit Program （PDF:204KB）
- IR
Notice Regarding Determination of Details of Stock Options (Share acquisition rights) （PDF:137KB）
- IR
Notice Concerning Partial Amendment to the Articles of Incorporation and Revision to the Year-End Dividend Forecast with Result from Share Split （PDF:224KB）
- IR
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2025 (unaudited) (Based on Japanese GAAP) （PDF:207KB）
- Information
Notice Concerning Acquisition of Business Goodwill and Inventories （PDF:226KB）
- IR
Notice Regarding Issuance of Stock Options (Share Acquisition Rights) （PDF:122KB）
- Products
The collaboration product “CLASSY COVERS EVO™” with FAVINI S.R.L. （PDF:2.91MB）
- IR
Notice of the 18th Annual General Meeting of Shareholders （PDF:251KB）
- Information
Notice Concerning Partial Amendments to the Articles of Incorporation （PDF:147KB）
- Information
Notice Concerning Organizational Changes and Changes in Officers （PDF:33.5KB）
- IR
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (unaudited) (Based on Japanese GAAP) （PDF:270KB）
There are no results matching your search.